Who uses Illumina NextSeq?

NextSeq is a benchtop short-read sequencer sized for a lab or core: RNA-seq, single-cell libraries, gene panels and exomes. It's made by Illumina. 4,385 bioRxiv and medRxiv preprints since April 2025 say they used NextSeq, 1,169 in the last 6 months. Updated daily (as of Nov 16)

Is NextSeq use still growing?

No: 1,169 preprints used NextSeq in Jun–Nov 2026, -19% vs the previous year as a share of all preprints. This is slower than short-read sequencers overall (+8%).

How does NextSeq compare with other short-read sequencers?

NextSeq is second, with 40% of their uses in Jun–Nov 2026, down from 53% the year before. NovaSeq X leads with 44%.

Preprints in the last 6 months

Growth, Jun–Nov 2026 vs Jun–Nov 2025

Which institutions use NextSeq most?

The institutions using NextSeq most are University of Washington, Stanford University and University of Pennsylvania.

Institutions

  1. University of Washington61
  2. Stanford University54
  3. University of Pennsylvania48
  4. Institut Pasteur48
  5. University of Pittsburgh40

Where the labs are

  • US46%
  • Germany9%
  • UK7%
  • France6%
  • Australia4%

The lab's institution and country are the corresponding author's.

Latest preprints using NextSeq

Who started using NextSeq recently?

189 institutions posted their first preprint using NextSeq since April 2025 in the last 6 months, including Real Jardín Botánico (CSIC), University of Colorado Anschutz Medical Campus and University of Salamanca.

  1. Real Jardín Botánico (CSIC)Jul 17, 2026
  2. University of Colorado Anschutz Medical CampusJul 23, 2026
  3. University of SalamancaJul 9, 2026
  4. Florey Institute of Neuroscience and Mental HealthJun 2, 2026
  5. Victor Chang Cardiac Research InstituteJun 10, 2026
  6. Earlham InstituteJun 15, 2026
  7. Justus Liebig University GiessenJun 26, 2026
  8. Shanghai Institute of Materia MedicaJul 10, 2026
  9. University of SurreyJul 17, 2026
  10. Aarhus UniversityAug 28, 2026

An institution counts as new when its first preprint using NextSeq since April 2025 was posted in the last 6 months; the date is that first preprint.

What do labs use alongside NextSeq?

Preprints using NextSeq most often also use Chromium, NovaSeq X and FACSymphony. The count is preprints using both.

What is NextSeq used for?

Preprints using NextSeq are most often in microbiology, cancer biology and immunology.

Fields

Microbiology 672Cancer biology 431Immunology 384Molecular biology 378Genomics 355Neuroscience 308

Where the work was published

  1. Nature Communications66
  2. Proceedings of the National Academy of Sciences41
  3. Nucleic Acids Research30
  4. Cell Reports26
  5. Scientific Reports24
  6. mBio23
How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.

Want to reach out to the labs using NextSeq?

Get the PIs behind the preprints: institutions, labs, and how to reach them.

Institutions with the most preprints using NextSeq